PUBLICATIONS & CASE STUDIES
Since its FDA approval in May 2007, the Mynx Vascular Closure Device has been published in numerous clinical and business journals. Included below are some of these published articles.
Note: Access Closure, Inc. is not responsible for the content presented in the following articles and website links.
Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal
Fargen KM, Velat GJ, Lawson MF, et al. J Neurointerv Surg. 2013;5(2):161-4
A Prospective Randomized Single-blind trial of Patient Comfort Following Vessel Closure
Extravascular Synthetic Sealant Closure Provides Less Pain than a Self-tightening Suture Vascular Compression Device.
Kyle M Fargen, MD et al. Journal of NeuroInterventional Surgery. Published Online First January2011
A Retrospective Review at a Single-Center with an Extravascular Closure Device.
Sonya Noor, MD et al. Vascular and Endovascular Surgery. 2010*
The Baptist Memorial Hospital experience revisited
David Wolford, MD, FACC. Endovascular Today. August 2010
A Case Review
Michael S. Fenster, MD. TCTMD. May 2009.
A Single-Center Evaluation
John Byron Patterson, MD. Cath Lab Digest. October 2009.
The Baptist Memorial Hospital Experience with the Mynx Vascular Closure Device
David Wolford, MD, FACC. Endovascular Today. August 2009.
Adopting Extravascular Closure Technology in the Catheterization Lab
Ameer Kabour, MD, FACC, FSCAI. Endovascular Today. May 2009.
The Piedmont Heart Institute Experience
Charles L. Brown III, MD, FACC, FACP. Cath Lab Digest. February 2009.
Results 27 Days Following Use of the Mynx Vascular Closure Device
Nishit Choksi, MD. TCTMD, May 2008.
Initial clinical experience using a novel approach to vascular closure
Gary M. Ansel, MD and Joseph M. Garasic, MD. Endovascular Today. January 2008.*
Initial Clinical Results for Mynx™
D. Scheinert MD et al. Catheterization and Cardiovascular Interventions. November 2007.
Research on Vascular Closure Devices
A Research Study
Stephen P. Marso, MD et al. JAMA 2010;303(21):2156-2164.
Results from the ACUITY Trial
Timothy A. Sanborn, MD et al. Circ Cardovasc Interv. 2010;3:57-62
*One or more authors of this article holds a financial ownership in AccessClosure. For more details, please contact the company.